The race to a COVID-19 vaccine: opportunities and challenges in development and distribution

Rodrigo M Burgos,Melissa E Badowski,Emily Drwiega,Samaneh Ghassemi,Nikki Griffith,Fischer Herald,Mikayla Johnson,Renata O Smith,Sarah M Michienzi
DOI: https://doi.org/10.7573/dic.2020-12-2
2021-02-15
Drugs in Context
Abstract:This article discusses the unprecedented toll of COVID-19 and how it jumpstarted the race towards potential COVID-19 vaccinations, which have been developed in less than a year. It discusses how this feat was accomplished, and how clinical development, manufacturing scale-up and distribution are occurring in parallel for the four COVID-19 vaccine front-runners. It also discusses the many challenges that still lie ahead.
What problem does this paper attempt to address?